CardioVascular sells vascular unit to Escalon
This article was originally published in Clinica
CardioVascular Dynamics is to sell its Vascular Access business unit to Escalon Medical, for an undisclosed sum. Escalon will make an initial payment for the assets and operations of the business and will continue royalty payments for the next five years.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.